A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study is designed to accurately assess any changes in blood pressure and pulse at 100 and
200 mg daily dose of milnacipran in patients with fibromyalgia syndrome.